Chester County News and Community Website
CONSHOHOCKEN, PA — Suvoda has introduced an artificial intelligence-driven system designed to reduce the time required to launch clinical trials, the company announced.
Suvoda Launches AI Tool to Speed Clinical Trial Startup Read More
KING OF PRUSSIA, PA — SEED Therapeutics, Inc. reported new preclinical data showing anticancer activity of its RBM39 degrader candidate ST-01156 in neuroblastoma and said the drug is being evaluated …
SEED Reports Preclinical Data on RBM39 Drug in Neuroblastoma Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) will present early results from a Phase 1 clinical trial of its WEE1 inhibitor APR-1051 at the 2026 American Society of Clinical …
Aprea Abstract Accepted for ASCO on APR-1051 Phase 1 Study Read More
PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) reported recently updated clinical data for its PBFT02 therapy in frontotemporal dementia and said it has initiated a strategic review process following …
Passage Bio Reports Trial Data, Reviews Strategic Options Read More
WASHINGTON, D.C. — Federal health officials are investing up to $139.4 million in new research to accelerate the development of mental health treatments, including emerging therapies such as digital tools, …
$139M Mental Health Push Aims to Speed New Treatments Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) will present clinical results from its QTORIN™ rapamycin program at the ISSVA World Congress 2026 in Philadelphia, with data from Phase 3 …
Palvella to Present QTORIN Study Data at ISSVA 2026 Conference Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) said it will present Phase 1 clinical data for its investigational drug Teverelix at the American Association of Clinical Endocrinology Annual Meeting, …
Medicus Pharma to Present Phase 1 Data on Teverelix at AACE 2026 Read More
WASHINGTON, D.C. — Federal regulators are pushing thousands of companies and researchers to disclose missing clinical trial results, warning that gaps in reporting may distort how drugs and medical products …
FDA Presses Firms to Report Missing Clinical Trial Results Read More PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) said it will present new Phase 1 clinical data on Teverelix, its investigational long-acting gonadotropin-releasing hormone antagonist, at the American Association of …
Medicus Pharma to Present Phase 1 Teverelix Data at Endocrinology Meeting Read More
MALVERN, PA — YPrime recently launched a new Participant Hub within its electronic clinical outcome assessment platform aimed at improving patient engagement and retention in clinical trials.
YPrime Launches eCOA Participant Hub to Improve Trial Engagement Read More